AUTL Autolus Therapeutics plc

NASDAQ
$1.14

Autolus Therapeutics plc (AUTL) Earnings News

Earnings press releases, previews and reviews for Autolus Therapeutics plc (AUTL), newest first. Our most recent is review: Autolus Beats on Revenue and Lifts Its Aucatzyl Outlook, but a Sequential Sales Dip and a Delayed MS Readout Complicate the Story.